Baidu
map

Nat Med:科学家揭秘基因如何影响机体应对病原体的免疫力

2016-07-06 佚名 生物谷

近日,刊登在国际杂志Nature Medicine上的一项研究报告中,来自格罗宁根大学医学中心等机构的研究人员通过研究揭示了健康个体机体中遗传因子如何控制免疫细胞对病原体的反应,文章中,研究者对200名志愿者进行研究,调查了当其受多种体外病原体刺激时免疫细胞的反应情况,同时研究者还将这些反应同400万个遗传性变异联系起来(即单核苷酸多态性)。 文章中研究者重点关注了免疫细胞如何使用细胞

近日,刊登在国际杂志Nature Medicine上的一项研究报告中,来自格罗宁根大学医学中心等机构的研究人员通过研究揭示了健康个体机体中遗传因子如何控制免疫细胞对病原体的反应,文章中,研究者对200名志愿者进行研究,调查了当其受多种体外病原体刺激时免疫细胞的反应情况,同时研究者还将这些反应同400万个遗传性变异联系起来(即单核苷酸多态性)。

文章中研究者重点关注了免疫细胞如何使用细胞因子来作为信号指导其对感染性因子产生反应,他们对来自人类功能基因组学计划中的200名参与者的血液样本进行分析,在实验室中研究者利用10种不同的细菌和真菌病原体对分离自血液中的免疫细胞进行刺激,随后在24小时及/或7小时后测定8种不同生长因子的反应。

不断改变的反应

研究者Kumar说道,我们在不同个体间观察到了细胞因子产生发生着较大的差异,这些反应对于不同的病原体非常特殊,这就表明,细胞因子会引发对病原体反应的改变,而且每一种感染都会诱发特殊的细胞因子反应通路。本文研究的关键是他们进行了一项大规模研究,即利用许多病原体并测定不同细胞因子的水平,下一步他们将去调查是否这些反应受到了遗传性的控制,在一组参与者中,研究者检测了400万个单核苷酸多态性(SNP)。

随后研究者发现了影响细胞因子反应的6个基因组区域,而且细胞因子的产生至少部分由遗传决定,其中一个典型的例子就是SNP,其可以影响GOLM1基因的表达,同样其也会高度表达来对病毒感染产生反应。研究者认为这或许和白色念珠菌感染的反应也存在明显的关联。

概念验证

研究者认为,当SNP的特殊突变存在时,细胞因子白细胞介素-6的产生就会降低,相关结果在念珠菌血症的患者中已经证实,念珠菌血症即真菌存在于血液中应引发感染,其和这些患者机体中相同的SNP及低水平的白细胞介素-6直接相关,因此遗传突变体的存在或许就导致其不能有效清除病原体。

最后研究者Kumar说道,本文研究中我们发现了细胞因子产生的多种突变,而且通过特殊的遗传组分解释了这些突变产生的原因,这就为后期开发治疗疾病的新型个体化疗法提供了新的思路和希望;当然相关研究或许也帮助研究者找到了新的遗传标志物来预测个体感染疾病的风险,而隐藏在不同易感性背后的遗传机制或许也可以帮助开发新型疾病疗法。

原始出处

Yang Li, Marije Oosting, Patrick Deelen, Isis Ricaño-Ponce, Sanne Smeekens, Martin Jaeger, Vasiliki Matzaraki, Morris A Swertz, Ramnik J Xavier, Lude Franke, Cisca Wijmenga, Leo A B Joosten, Vinod Kumar & Mihai G Netea.Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi.Nat Med.2016


 

Little is known about the inter-individual variation of cytokine responses to different pathogens in healthy individuals. To systematically describe cytokine responses elicited by distinct pathogens and to determine the effect of genetic variation on cytokine production, we profiled cytokines produced by peripheral blood mononuclear cells from 197 individuals of European origin from the 200 Functional Genomics (200FG) cohort in the Human Functional Genomics Project (http://www.humanfunctionalgenomics.org), obtained over three different years. We compared bacteria- and fungi-induced cytokine profiles and found that most cytokine responses were organized around a physiological response to specific pathogens, rather than around a particular immune pathway or cytokine. We then correlated genome-wide single-nucleotide polymorphism (SNP) genotypes with cytokine abundance and identified six cytokine quantitative trait loci (QTLs). Among them, a cytokine QTL at the NAA35-GOLM1 locus markedly modulated interleukin (IL)-6 production in response to multiple pathogens and was associated with susceptibility to candidemia. Furthermore, the cytokine QTLs that we identified were enriched among SNPs previously associated with infectious diseases and heart diseases. These data reveal and begin to explain the variability in cytokine production by human immune cells in response to pathogens.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1881153, encodeId=a06a18811533e, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Sep 13 05:29:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307690, encodeId=8d6e130e690cf, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510625, encodeId=0d7a1510625c7, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606971, encodeId=8f6e16069e1dc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92191, encodeId=93119219122, content=涨姿势了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Jul 07 09:12:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92137, encodeId=c8dc9213e33, content=有没有安纳咖, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a061744395, createdName=来福士, createdTime=Wed Jul 06 14:57:00 CST 2016, time=2016-07-06, status=1, ipAttribution=)]
    2016-09-13 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1881153, encodeId=a06a18811533e, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Sep 13 05:29:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307690, encodeId=8d6e130e690cf, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510625, encodeId=0d7a1510625c7, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606971, encodeId=8f6e16069e1dc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92191, encodeId=93119219122, content=涨姿势了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Jul 07 09:12:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92137, encodeId=c8dc9213e33, content=有没有安纳咖, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a061744395, createdName=来福士, createdTime=Wed Jul 06 14:57:00 CST 2016, time=2016-07-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1881153, encodeId=a06a18811533e, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Sep 13 05:29:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307690, encodeId=8d6e130e690cf, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510625, encodeId=0d7a1510625c7, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606971, encodeId=8f6e16069e1dc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92191, encodeId=93119219122, content=涨姿势了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Jul 07 09:12:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92137, encodeId=c8dc9213e33, content=有没有安纳咖, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a061744395, createdName=来福士, createdTime=Wed Jul 06 14:57:00 CST 2016, time=2016-07-06, status=1, ipAttribution=)]
    2016-07-08 xue8605
  4. [GetPortalCommentsPageByObjectIdResponse(id=1881153, encodeId=a06a18811533e, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Sep 13 05:29:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307690, encodeId=8d6e130e690cf, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510625, encodeId=0d7a1510625c7, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606971, encodeId=8f6e16069e1dc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92191, encodeId=93119219122, content=涨姿势了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Jul 07 09:12:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92137, encodeId=c8dc9213e33, content=有没有安纳咖, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a061744395, createdName=来福士, createdTime=Wed Jul 06 14:57:00 CST 2016, time=2016-07-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1881153, encodeId=a06a18811533e, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Sep 13 05:29:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307690, encodeId=8d6e130e690cf, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510625, encodeId=0d7a1510625c7, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606971, encodeId=8f6e16069e1dc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92191, encodeId=93119219122, content=涨姿势了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Jul 07 09:12:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92137, encodeId=c8dc9213e33, content=有没有安纳咖, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a061744395, createdName=来福士, createdTime=Wed Jul 06 14:57:00 CST 2016, time=2016-07-06, status=1, ipAttribution=)]
    2016-07-07 oo902

    涨姿势了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1881153, encodeId=a06a18811533e, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Sep 13 05:29:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307690, encodeId=8d6e130e690cf, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510625, encodeId=0d7a1510625c7, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606971, encodeId=8f6e16069e1dc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 08 02:29:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92191, encodeId=93119219122, content=涨姿势了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Thu Jul 07 09:12:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92137, encodeId=c8dc9213e33, content=有没有安纳咖, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a061744395, createdName=来福士, createdTime=Wed Jul 06 14:57:00 CST 2016, time=2016-07-06, status=1, ipAttribution=)]
    2016-07-06 来福士

    有没有安纳咖

    0

相关资讯

测测你还有多少免疫力可以“挥霍”?——中国学者绘出人体免疫系统衰老变化趋势图

人们常说,年纪大了免疫力会下降。那么随着年龄的增长,人体内的免疫系统是如何发生相应变化的?“衰老”有没有可测量的指标和参考值?北京协和医院感染内科李太生等历时10年完成的一项大规模健康人群免疫功能研究,在国际上首次揭示了健康人群免疫功能指标(即外周血淋巴细胞亚群)的各年龄段正常参考值范围以及其随年龄变化趋势。论文日前发表在衰老领域影响因子国际排名第一的《衰老(Aging)》杂志上,被认为是淋巴细胞

HPV感染须进行联合彻底治疗

HPV感染须进行联合彻底治疗 ——访首都医科大学附属北京同仁医院皮肤性病科主任杨秀敏教授     人乳头瘤病毒(HPV)是最小的球形双链DNA病毒,广泛存在于自然界。目前已发现上百种HPV亚型,不同型别的HPV病毒致病性不同,临床常见约40多种HPV亚型可以引发不同的疾病,高危型HPV感染具有致癌性。从HPV感染到产生癌变,是一个渐进的过程。在此期间病变处于变

上海**妇婴保健院教授李芳谈HPV感染的防治

李芳人乳头瘤病毒(Human Papilloma Virus, HPV)是广泛存在于自然界的非活性DNA病毒,具有宿主和组织特异性。目前已经发现上百种HPV亚型,分为低危型和高危型两大类。虽然HPV只侵犯人体皮肤和黏膜的鳞状上皮,但会引起皮肤黏膜的良性及恶性病变,是导致宫颈癌的首要因素,尤其是高危型HPV,如HPV-16、18型与宫颈癌的发生密切相关。德国癌症研究中心的科学家Harald zu

宝宝的免疫力好不好,妈妈的肠道微生物是关键!

大家最近有没有去公园踏青赏花呀?厚重的冬天终于过去了,天气一转暖,户外的花也都开了,但是对于花粉过敏的朋友们来说,“满园春色”恐怕没有听起来那么美好。 春天是个过敏高发的季节,说起过敏,大家可能都知道,这是一种免疫系统疾病,而免疫系统是人体内的“堤坝”,我们生病与痊愈几乎都离不开它。 一直以来,科研人员们都认为,从我们出生开始,我们自身的肠道微生物就在一点一点塑

Aging:中国学者绘出人体免疫系统衰老变化趋势图

在一项新的研究中,来自日本熊本大学和英国帝国理工学院的研究人员鉴定出人T细胞白血病病毒1型(human T-cell leukemia virus type 1, HTLV-1)在人体内建立持续性潜伏感染机制。这是一个重要的成就,可能有助于预防难治的白血病---在该疾病中,白血病细胞对治疗的反应并不良好。相关研究结果近期发表在PNAS期刊上,论文标题为“The retrovirus HTLV-1

运动时间太长,竟然有损免疫力?!

前段时间界哥刚刚介绍过一种适合超级懒人的1分钟锻炼法,在那项研究中主导者认为1分钟的高强度锻炼效果也是很好的,实在受不了长时间锻炼又害怕血糖血脂夺命连环call的懒人们可以试试。 有意思的是,《美国运动医学学会杂志》刊发了一篇文章,干脆就说——不要搞长时间锻炼,因为一次锻炼时间太长,有损免疫力! 真的假的?什么情况? 这篇虽然发表在美国杂志上主要却是由英国

Baidu
map
Baidu
map
Baidu
map